Teresa Lopez-Castro to Humans
This is a "connection" page, showing publications Teresa Lopez-Castro has written about Humans.
Connection Strength
0.265
-
L?pez-Castro T, Gette JA, Back SE, Blakey SM, Killeen TK, Morgan-Lopez AA, Norman SB, Ruglass LM, Saavedra LM, McGovern MP, Petrakis IL, Sonne S, Ehring T, Brady KT, Hien DA. World Health Organization risk drinking level reductions as treatment outcomes in PTSD and substance use disorder trials. Drug Alcohol Depend. 2025 Oct 01; 275:112837.
Score: 0.043
-
L?pez-Castro T, Sohler N, Riback L, Bravo G, Ohlendorf E, Ghiroli M, Fox AD. Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care. Harm Reduct J. 2024 06 01; 21(1):108.
Score: 0.039
-
L?pez-Castro T, Jakubowski A, Masyukova M, Peterson M, Pierz A, Kodali S, Arnsten JH, Starrels JL, Nahvi S. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic. J Subst Use Addict Treat. 2024 02; 157:209235.
Score: 0.038
-
Saavedra LM, Morgan-L?pez AA, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, Lopez-Castro T. Putting the Patient Back in Clinical Significance: Moderated Nonlinear Factor Analysis for Estimating Clinically Significant Change in Treatment for Posttraumatic Stress Disorder. J Trauma Stress. 2021 04; 34(2):454-466.
Score: 0.031
-
L?pez-Castro T, Smith KZ, Nicholson RA, Armas A, Hien DA. Does a history of violent offending impact treatment response for comorbid PTSD and substance use disorders? A secondary analysis of a randomized controlled trial. J Subst Abuse Treat. 2019 02; 97:47-58.
Score: 0.027
-
Saraiya TC, Jones AC, Lopez-Castro T, Hood CO, Flores J, Badour CL. Trauma-related shame predicts daily non-medical prescription opioid use among individuals with PTSD symptoms. J Psychiatr Res. 2024 03; 171:171-176.
Score: 0.010
-
Ohlendorf E, Perez-Correa A, Riback L, Ghiroli M, Lopez-Castro T, Fox AD. Treatment History and Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among People Who Inject Drugs. J Addict Med. 2023 May-Jun 01; 17(3):e148-e155.
Score: 0.009
-
Jakubowski A, Rath C, Harocopos A, Wright M, Welch A, Kattan J, Navos Behrends C, Lopez-Castro T, Fox AD. Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation. Harm Reduct J. 2022 07 10; 19(1):75.
Score: 0.009
-
Im S, Fitzpatrick S, Hien DA, Lopez-Castro T, Pawlak A, Melara RD. Frontal Alpha Asymmetry in Children with Trauma Exposure. Clin EEG Neurosci. 2022 Sep; 53(5):418-425.
Score: 0.008
-
Hien DA, Fitzpatrick S, Saavedra LM, Ebrahimi CT, Norman SB, Tripp J, Ruglass LM, Lopez-Castro T, Killeen TK, Back SE, Morgan-L?pez AA. What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders. Eur J Psychotraumatol. 2022; 13(1):2001191.
Score: 0.008
-
Hien D, Kropp F, Wells EA, Campbell A, Hatch-Maillette M, Hodgkins C, Killeen T, Lopez-Castro T, Morgan-Lopez A, Ruglass LM, Saavedra L, Nunes EV. The "Women and Trauma" study and its national impact on advancing trauma specific approaches in community substance use treatment and research. J Subst Abuse Treat. 2020 03; 112S:12-17.
Score: 0.007
-
Fitzpatrick S, Saraiya T, Lopez-Castro T, Ruglass LM, Hien D. The impact of trauma characteristics on post-traumatic stress disorder and substance use disorder outcomes across integrated and substance use treatments. J Subst Abuse Treat. 2020 06; 113:107976.
Score: 0.007
-
Hien DA, Lopez-Castro T, Papini S, Gorman B, Ruglass LM. Emotion dysregulation moderates the effect of cognitive behavior therapy with prolonged exposure for co-occurring PTSD and substance use disorders. J Anxiety Disord. 2017 Dec; 52:53-61.
Score: 0.006
-
Ruglass LM, Lopez-Castro T, Papini S, Killeen T, Back SE, Hien DA. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial. Psychother Psychosom. 2017; 86(3):150-161.
Score: 0.006
-
Papini S, Ruglass LM, Lopez-Castro T, Powers MB, Smits JA, Hien DA. Chronic cannabis use is associated with impaired fear extinction in humans. J Abnorm Psychol. 2017 Jan; 126(1):117-124.
Score: 0.006
-
Papini S, Yoon P, Rubin M, Lopez-Castro T, Hien DA. Linguistic characteristics in a non-trauma-related narrative task are associated with PTSD diagnosis and symptom severity. Psychol Trauma. 2015 May; 7(3):295-302.
Score: 0.005
-
Ruglass LM, Lopez-Castro T, Cheref S, Papini S, Hien DA. At the crossroads: the intersection of substance use disorders, anxiety disorders, and posttraumatic stress disorder. Curr Psychiatry Rep. 2014 Nov; 16(11):505.
Score: 0.005